Differences in the cellular uptake and intracellular itineraries of amyloid beta proteins 40 and 42: ramifications for the Alzheimer's drug discovery.

Omtri RS, Davidson MW, Arumugam B, Poduslo JF, Kandimalla KK. Differences in the cellular uptake and intracellular itineraries of amyloid beta proteins 40 and 42: ramifications for the Alzheimer's drug discovery. Mol Pharm. 2012 Jul 02; 9(7):1887-97.

View in: PubMed

subject areas

Alzheimer Disease
Animals
Caveolin 1
Cell Line, Tumor
Drug Discovery
Endocytosis
Endosomes
Lysosomes
Neurons
PC12 Cells
Peptide Fragments
Rats

authors with profiles

Karunya Kandimalla
Michael Davidson

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support